Review Article
Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus
Table 1
Anticancer functions of calycosin
| Biomarkers | Model | Reference |
| Cleaved caspase 3/9 upregulation; enhanced Bax/Bcl-2 ratio | MCF-7 cells; MDA-MB231 cells | Tian et al. [14]; Tian et al. [15] | Reduced cell migration and invasion; enhanced apoptosis rate via blocking IGF-1R pathway; downregulated VEGF and MMP | MCF-7 cells; T47D cells | Li et al. [16]; Chen et al. [17]; Chen et al. [18] | Downregulation of Rab27B and β-catenin | MDA-MB-231 cells | Wu et al. [19] | Abnormal expression levels of ERα, ERβ, ATP-binding cassette subfamily G member 2, breast cancer type 1 susceptibility protein, p450, and EGFR | OMIM data | Huang et al. [22] | Colorectal cancer proliferation | SW480 cells | Zhao et al. [25] | Beclin-1 and LC-3II overexpression | HT-29 cells | EI-kott et al. [26] | Upregulation of ERβ and PTEN | HCT-116 cells | Chen et al. [28] | Induced osteosarcoma apoptosis and decrease MMP2 | MG-63 cells | Qiu et al. [31] | Reduced tumor size and PI3K/Akt phosphorylation | Nude mice | Wang et al. [32]; Qiu et al. [31]; Tian et al. [33] |
|
|